M.D. Anderson Cancer Center: Breast Neoplasms trials

The registry lists 201 Breast Neoplasms studies with M.D. Anderson Cancer Center as lead sponsor. 28 are open to participants now and 50 have results posted.

Early Phase 1 3Phase 1 41Phase 2 64Phase 3 12Phase 4 1No phase 93(a study in two phases counts in both)

Studies

Page 2 of 3. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Development of a Patient Decision Aid for Women Considering Breast ReconstructionCompletedNCT04817709
• What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven CareWithdrawnNCT04794816
• Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA TrialWithdrawnNCT04756505Phase 1
• Acceptability of 3D Printed Breast Models as Surgical Decision Aids for Breast Cancer TreatmentCompletedNCT04693364
• Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their RelativesCompletedNCT04257045
• Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast CancerCompletedNCT04087057
• Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast CancerCompletedNCT04022772Not applicable
• An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast ReconstructionActive, not recruitingNCT03990610Not applicable
• Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing ChemotherapyCompletedNCT03964896Not applicable
• ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid TumorsCompletedNCT03725436Phase 1
• M7824 in Treating Patients With Stage II-III HER2 Positive Breast CancerCompletedNCT03620201Phase 1
• M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast CancerTerminatedNCT03579472Phase 1
• Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast CancerCompletedNCT03524170Phase 1
• Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NTActive, not recruitingNCT03435952Phase 1
• An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast CancerActive, not recruitingNCT03429907Not applicable
• IACS-010759 in Advanced CancersCompletedNCT03291938Phase 1
• Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast CancerCompletedNCT03207529Phase 1
• 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in PatientsActive, not recruitingNCT03168737Phase 1
• Selumetinib and Olaparib in Solid TumorsActive, not recruitingNCT03162627Phase 1
• Decision Aid Website in Helping to Make Decisions About Fertility in Participants With CancerActive, not recruitingNCT03141437Not applicable
• Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast CancerSuspendedNCT03077841Phase 2/3
• Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing SurgeryCompletedNCT03038152Phase 4
• A Culturally Sensitive Social Support InterventionCompletedNCT02946697Not applicable
• Lenvatinib and Capecitabine in Patients With Advanced MalignanciesWithdrawnNCT02915172Phase 1
• Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast CancerActive, not recruitingNCT02912312Phase 2
• Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast CancerActive, not recruitingNCT02876107Phase 2
• Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer TreatmentActive, not recruitingNCT02754752Phase 2
• Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast CancerCompletedNCT02590458Early Phase 1
• Feasibility and Identification of Breast Cancer Patients for Potential Avoidance of SurgeryActive, not recruitingNCT02455791Not applicable
• Effects of a Group Residential Retreat on Cancer OutcomesWithdrawnNCT02429544Not applicable
• Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesTerminatedNCT02419495Phase 1
• Mindfulness Based Couples TherapyCompletedNCT02349217Not applicable
• Tc99m Sestamibi Molecular Breast ImagingActive, not recruitingNCT02324387Not applicable
• Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot InitiativeActive, not recruitingNCT02276443Not applicable
• Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast MalignanciesActive, not recruitingNCT02221700Not applicable
• mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and OvarianActive, not recruitingNCT02208375Phase 1
• Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family MembersActive, not recruitingNCT02194387Not applicable
• Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsCompletedNCT02152943Phase 1
• The Role of Lifestyle Factors in Breast Cancer-Related OutcomesActive, not recruitingNCT02079662Not applicable
• Selective Image Guided Resection of Axillary Lymph NodesCompletedNCT01880645Not applicable
• Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRGTerminatedNCT01815346Phase 1/2
• Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast CancerTerminatedNCT01755130Not applicable
• The Effect of Dexmedetomidine of the Immune SystemCompletedNCT01692210
• Technology and Navigation to Improve Survivorship CareStatus unknownNCT01663870
• Preventing Sexual Dysfunction With Aromatase InhibitorsCompletedNCT01603303Phase 2
• Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTerminatedNCT01552434Phase 1
• Lifestyle Intervention for High Risk Cancer SurvivorsCompletedNCT01508273Not applicable
• Part II: Exercise in Hispanic Breast Cancer SurvivorsActive, not recruitingNCT01504789Not applicable
• Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on TrastuzumabWithdrawnNCT01479179Phase 1/2
• Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)WithdrawnNCT01333423Phase 1
• Delayed-Delayed Breast ReconstructionCompletedNCT01256528Not applicable
• Radiation Therapy in Treating Patients With Stage 0-II Breast CancerActive, not recruitingNCT01245712Phase 2
• Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast CancerCompletedNCT01207635
• Relaxation for Women With Breast Cancer Undergoing RadiotherapyActive, not recruitingNCT01202851Phase 3
• Molecular Triaging of Newly Diagnosed Breast CancerWithdrawnNCT01159236Not applicable
• The Impact of Obesity and Obesity Treatments on Breast CancerCompletedNCT00933309Phase 1
• Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer PatientsActive, not recruitingNCT00929214Phase 2
• Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation TherapyTerminatedNCT00925405
• Automated Pain Intervention for Underserved Minority Breast Cancer PatientsCompletedNCT00881010
• Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S.CompletedNCT00837499
• Topical Cyclosporine vs. Placebo for Epiphora Associated With DocetaxelWithdrawnNCT00824811Phase 2
• Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer PatientsCompletedNCT00806507
• Lynne Cohen Consortium Project: Multi-Center Database/RegistryCompletedNCT00776958
• Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase InhibitorsTerminatedNCT00738998Not applicable
• Quantitative Analysis of Outcomes in Breast ReconstructionCompletedNCT00677430
• Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer PatientsCompletedNCT00658281
• Axillary Reverse Mapping for Invasive Carcinoma of the BreastCompletedNCT00645541Phase 1
• Magnetic Resonance Imaging in Patients With Breast CancerCompletedNCT00610181
• Meditation and Cognitive Function in Women With Breast CancerCompletedNCT00556218Not applicable
• A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing MastectomyCompletedNCT00539227
• Neuropathic Pain in Survivors of Breast CancerCompletedNCT00535067
• Weight Gain Prevention for Breast Cancer SurvivorsStatus unknownNCT00533338Not applicable
• Effect on Clip Markers After Vacuum-Assisted Biopsy by Postprocedure MammogramCompletedNCT00529737Not applicable
• Cancer Genetics CD-ROM for HispanicsCompletedNCT00525980Not applicable
• Primary Breast Cancer Occurring Concomitant With PregnancyCompletedNCT00510367Early Phase 1
• Effects of Yoga in Breast Cancer PatientsCompletedNCT00508794Not applicable
• Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)Active, not recruitingNCT00508443Phase 1/2
• Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast CancerCompletedNCT00507923Not applicable
• 3-Dimensional Form and Soft Tissue Biomechanics of the BreastTerminatedNCT00502814
• Pain Management Following TRAM Flap for Breast ReconstructionCompletedNCT00500565Not applicable
• Pre-Surgical Qigong Therapy for Women With Breast CancerCompletedNCT00495209
• Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast CancerCompletedNCT00493350
• Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast CancerCompletedNCT00490503
• Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to CapecitabineCompletedNCT00478686
• Delayed-Immediate Breast ReconstructionCompletedNCT00473122Phase 2
• Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast CancerCompletedNCT00438477Not applicable
• Bone Response in Metastatic Breast Cancer Involving BonesCompletedNCT00420433
• Spousal Relationships and Pain in Metastatic Breast CancerCompletedNCT00386620
• Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast CancerCompletedNCT00336791Phase 3
• CT-2103 in Combination With Gemcitabine in Metastatic Breast CancerCompletedNCT00270907Phase 1
• RAD001 Plus Docetaxel in Patients With Metastatic Breast CancerTerminatedNCT00253318Phase 1
• Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast CancerTerminatedNCT00227656Phase 2
• Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid TumorsCompletedNCT00078845Phase 2
• Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast CancerCompletedNCT00046865Phase 3
• Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast CancerCompletedNCT00038402Phase 3
• Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer PatientsCompletedNCT00037609Phase 1/2
• Docetaxel in Treating Patients With Metastatic Breast CancerCompletedNCT00008411Phase 3
• Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast CancerCompletedNCT00005991Phase 2
• Chemoprevention Therapy Plus Surgery in Treating Women With Breast CancerCompletedNCT00003099Phase 2
• High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast CancerCompletedNCT00002837Phase 1/2